Status | Study |
Recruiting |
Study Name: Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging Condition: Heart Failure Iron Overload Cardiomyopathies Date: 2015-08-17 Interventions: Other: MR T2* imaging Cardiac magnetic resonance imaging with T2* imaging |
Completed |
Study Name: Amlodipine for Myocardial Iron in Thalassemia Condition: Thalassemia Date: 2014-02-17 Interventions: Drug: Standard Chelation This |
Completed |
Study Name: Multi-Center Study of Iron Overload: Survey Study (MCSIO) Condition: Sickle Cell Disease Thalassemia Diamond-Blackfan Anemia Date: 2013-07-30 |
Terminated |
Study Name: Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome Condition: Hemochromatosis Myelodysplastic Syndromes Date: 2013-07-01 Interventions: Drug: Deferasirox Deferasirox |
Active, not recruiting |
Study Name: Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy Condition: Intracerebral Hemorrhage Cerebral Amyloid Angiopathy Ische Date: 2013-05-15 |
Completed |
Study Name: An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) Condition: Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia Date: 2012-11-26 Interventions: Device: MRI scan MRI was used to measure both liver and cardiac iron loading (R2 by FerriScan and T2*, r |
Completed |
Study Name: A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months Condition: Multiple Sclerosis Date: 2012-09-26 Interventions: Other: MRI All subjects will undergo a MRI. |
Active, not recruiting |
Study Name: Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis Condition: Superficial Siderosis Date: 2011-01-20 |
Active, not recruiting |
Study Name: Assessment of Iron Deposition in Major Organs of Hemodialysis Patients Condition: Iron Overload Date: 2010-07-23 |
Completed |
Study Name: Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial Condition: Multiple Sclerosis Date: 2010-03-10 Interventions: Drug: Rebif 44 mcg tiw |